U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 188

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:10544471
GRCh38:
Chr17:10641154
MYH3V699DFreeman-Sheldon syndromeLikely pathogenic
(Jul 1, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr17:10551906
GRCh38:
Chr17:10648589
MYH3K235EArthrogryposis, distal, type 2B3, Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A, Freeman-Sheldon syndrome
Likely pathogenic
(Jul 20, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr17:10542360-10542362
GRCh38:
Chr17:10639043-10639045
MYH3Freeman-Sheldon syndromeLikely pathogenic
(Jun 18, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr17:10543771
GRCh38:
Chr17:10640454
MYH3G769SFreeman-Sheldon syndromeUncertain significance
(Jan 6, 2022)
no assertion criteria provided
5.
GRCh37:
Chr17:10552000-10552001
GRCh38:
Chr17:10648683-10648684
MYH3Arthrogryposis, distal, type 2B3, Contractures, pterygia, and variable skeletal fusions syndrome 1B, not provided,
Freeman-Sheldon syndrome, Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A
Benign
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr17:10543282-10543283
GRCh38:
Chr17:10639965-10639966
MYH3Contractures, pterygia, and variable skeletal fusions syndrome 1B, Arthrogryposis, distal, type 2B3, Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A,
not provided, Freeman-Sheldon syndrome
Benign
(Sep 5, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr17:10554978
GRCh38:
Chr17:10651661
MYH3S119LFreeman-Sheldon syndromeUncertain significance
(Feb 1, 2021)
criteria provided, single submitter
8.
GRCh37:
Chr17:10543035
GRCh38:
Chr17:10639718
MYH3V923Lnot provided, Freeman-Sheldon syndromeUncertain significance
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr17:10542911
GRCh38:
Chr17:10639594
MYH3K964RFreeman-Sheldon syndrome, Arthrogryposis, distal, type 2B3Uncertain significance
(Apr 3, 2020)
criteria provided, single submitter
10.
GRCh37:
Chr17:10543472
GRCh38:
Chr17:10640155
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Sep 21, 2022)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr17:10555788
GRCh38:
Chr17:10652471
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr17:10555787
GRCh38:
Chr17:10652470
MYH3P100SFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Conflicting interpretations of pathogenicity
(Jan 12, 2018)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr17:10555738
GRCh38:
Chr17:10652421
MYH3Y116Cnot provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Apr 25, 2022)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr17:10545741
GRCh38:
Chr17:10642424
MYH3not provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Aug 3, 2022)
criteria provided, conflicting interpretations
15.
GRCh37:
Chr17:10549035
GRCh38:
Chr17:10645718
MYH3D377GFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr17:10543086
GRCh38:
Chr17:10639769
MYH3C906SFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
17.
GRCh37:
Chr17:10554817
GRCh38:
Chr17:10651500
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
18.
GRCh37:
Chr17:10553715
GRCh38:
Chr17:10650398
MYH3R170HFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
19.
GRCh37:
Chr17:10552965
GRCh38:
Chr17:10649648
MYH3R191Wnot provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Oct 21, 2022)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr17:10555878
GRCh38:
Chr17:10652561
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr17:10545994
GRCh38:
Chr17:10642677
MYH3K543MFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
22.
GRCh37:
Chr17:10543478
GRCh38:
Chr17:10640161
MYH3not provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Aug 16, 2022)
criteria provided, conflicting interpretations
23.
GRCh37:
Chr17:10534983
GRCh38:
Chr17:10631666
MYH3D1744GFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Sep 2, 2022)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr17:10534964
GRCh38:
Chr17:10631647
MYH3not provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Jul 25, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr17:10532008
GRCh38:
Chr17:10628691
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Benign/Likely benign
(Sep 20, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr17:10542277
GRCh38:
Chr17:10638960
MYH3K1084NFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
27.
GRCh37:
Chr17:10542259
GRCh38:
Chr17:10638942
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
28.
GRCh37:
Chr17:10541495
GRCh38:
Chr17:10638178
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(May 24, 2022)
criteria provided, conflicting interpretations
29.
GRCh37:
Chr17:10538708
GRCh38:
Chr17:10635391
MYH3R1383HFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Uncertain significance
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr17:10536015
GRCh38:
Chr17:10632698
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
31.
GRCh37:
Chr17:10535997
GRCh38:
Chr17:10632680
MYH3not provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Oct 1, 2021)
criteria provided, conflicting interpretations
32.
GRCh37:
Chr17:10534961
GRCh38:
Chr17:10631644
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Mar 12, 2022)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr17:10541644
GRCh38:
Chr17:10638327
MYH3E1149QDistal arthrogryposis type 2B1, Freeman-Sheldon syndrome, not provided
Benign/Likely benign
(Sep 18, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr17:10541371
GRCh38:
Chr17:10638054
MYH3S1240Tnot provided, Inborn genetic diseases, Freeman-Sheldon syndrome,
Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Jun 16, 2023)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr17:10538310
GRCh38:
Chr17:10634993
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Jul 19, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr17:10535808
GRCh38:
Chr17:10632491
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Benign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr17:10535338
GRCh38:
Chr17:10632021
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
38.
GRCh37:
Chr17:10535256
GRCh38:
Chr17:10631939
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
39.
GRCh37:
Chr17:10541621
GRCh38:
Chr17:10638304
MYH3not provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Oct 14, 2022)
criteria provided, conflicting interpretations
40.
GRCh37:
Chr17:10541557
GRCh38:
Chr17:10638240
MYH3D1178Nnot provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr17:10541132
GRCh38:
Chr17:10637815
MYH3E1284Knot provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Aug 6, 2022)
criteria provided, conflicting interpretations
42.
GRCh37:
Chr17:10539082
GRCh38:
Chr17:10635765
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
43.
GRCh37:
Chr17:10537405
GRCh38:
Chr17:10634088
MYH3K1484RDistal arthrogryposis type 2B1, not provided, Freeman-Sheldon syndrome
Benign/Likely benign
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr17:10537026
GRCh38:
Chr17:10633709
MYH3I1510TDistal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr17:10536964
GRCh38:
Chr17:10633647
MYH3R1531GFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr17:10536920
GRCh38:
Chr17:10633603
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1, not provided
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr17:10535238
GRCh38:
Chr17:10631921
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1, not provided
Conflicting interpretations of pathogenicity
(Oct 5, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr17:10555064-10555065
GRCh38:
Chr17:10651747-10651748
MYH3not provided, Freeman-Sheldon syndromeBenign
(Oct 2, 2019)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr17:10555061
GRCh38:
Chr17:10651744
MYH3not provided, Freeman-Sheldon syndromeBenign
(Sep 4, 2019)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:10535429-10535433
GRCh38:
Chr17:10632112-10632116
MYH3not provided, Freeman-Sheldon syndromeBenign
(Sep 4, 2019)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:10535216
GRCh38:
Chr17:10631899
MYH3T1692Anot provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Benign/Likely benign
(Oct 16, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr17:10533761
GRCh38:
Chr17:10630444
MYH3not provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Oct 28, 2022)
criteria provided, conflicting interpretations
53.
GRCh37:
Chr17:10538863
GRCh38:
Chr17:10635546
MYH3not provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Oct 7, 2022)
criteria provided, conflicting interpretations
54.
GRCh37:
Chr17:10552886
GRCh38:
Chr17:10649569
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome, not provided
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
55.
GRCh37:
Chr17:10541700
GRCh38:
Chr17:10638383
MYH3R1130Hnot provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Benign/Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr17:10546158
GRCh38:
Chr17:10642841
MYH3not provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Benign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
57.
GRCh37:
Chr17:10535223
GRCh38:
Chr17:10631906
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome, not provided
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr17:10535939
GRCh38:
Chr17:10632622
MYH3A1604Tnot provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Sep 18, 2022)
criteria provided, conflicting interpretations
59.
GRCh37:
Chr17:10554881
GRCh38:
Chr17:10651564
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Benign/Likely benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr17:10538758
GRCh38:
Chr17:10635441
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr17:10545874
GRCh38:
Chr17:10642557
MYH3Y583SFreeman-Sheldon syndromePathogenic
(Aug 21, 2019)
criteria provided, single submitter
62.
GRCh37:
Chr17:10559461
GRCh38:
Chr17:10656144
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndromeBenign/Likely benign
(Jan 13, 2018)
criteria provided, single submitter
63.
GRCh37:
Chr17:10559442
GRCh38:
Chr17:10656125
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
64.
GRCh37:
Chr17:10559429
GRCh38:
Chr17:10656112
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
65.
GRCh37:
Chr17:10559403
GRCh38:
Chr17:10656086
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
66.
GRCh37:
Chr17:10558363
GRCh38:
Chr17:10655046
MYH3M7Vnot provided, Distal arthrogryposis type 2B1, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Nov 30, 2021)
criteria provided, conflicting interpretations
67.
GRCh37:
Chr17:10558216
GRCh38:
Chr17:10654899
MYH3Q56Enot provided, Freeman-Sheldon syndrome, Inborn genetic diseases,
Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr17:10555837
GRCh38:
Chr17:10652520
MYH3P83RFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1,
MYH3-Related Disorders
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
69.
GRCh37:
Chr17:10555833
GRCh38:
Chr17:10652516
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1,
not specified
Benign/Likely benign
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:10554922
GRCh38:
Chr17:10651605
MYH3E138KFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:10554894
GRCh38:
Chr17:10651577
MYH3K147RDistal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr17:10554875
GRCh38:
Chr17:10651558
MYH3Distal arthrogryposis type 2B1, Freeman-Sheldon syndromeUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr17:10552884
GRCh38:
Chr17:10649567
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr17:10550749
GRCh38:
Chr17:10647432
MYH3Distal arthrogryposis type 2B1, not provided, Freeman-Sheldon syndrome
Conflicting interpretations of pathogenicity
(Oct 20, 2022)
criteria provided, conflicting interpretations
75.
GRCh37:
Chr17:10550602
GRCh38:
Chr17:10647285
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Sep 24, 2021)
criteria provided, conflicting interpretations
76.
GRCh37:
Chr17:10549338
GRCh38:
Chr17:10646021
MYH3I304VFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
77.
GRCh37:
Chr17:10549103
GRCh38:
Chr17:10645786
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr17:10548022
GRCh38:
Chr17:10644705
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
79.
GRCh37:
Chr17:10547950
GRCh38:
Chr17:10644633
MYH3R404TFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1, Inborn genetic diseases
Uncertain significance
(Dec 21, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr17:10546313
GRCh38:
Chr17:10642996
MYH3Y471HFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Oct 30, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr17:10546203
GRCh38:
Chr17:10642886
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Benign/Likely benign
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr17:10546046
GRCh38:
Chr17:10642729
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
83.
GRCh37:
Chr17:10545919
GRCh38:
Chr17:10642602
MYH3K568RFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(May 15, 2022)
criteria provided, conflicting interpretations
84.
GRCh37:
Chr17:10545915
GRCh38:
Chr17:10642598
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Mar 9, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr17:10545750
GRCh38:
Chr17:10642433
MYH3Freeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Sep 8, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr17:10545724
GRCh38:
Chr17:10642407
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Conflicting interpretations of pathogenicity
(Jan 13, 2018)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr17:10545584
GRCh38:
Chr17:10642267
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1, not provided
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr17:10544697
GRCh38:
Chr17:10641380
MYH3Freeman-Sheldon syndrome, Arthrogryposis multiplex congenita, Arthrogryposis, distal, type 2B3,
Contractures, pterygia, and variable skeletal fusions syndrome 1B, Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A, not provided
Benign/Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr17:10544696-10544697
GRCh38:
Chr17:10641379-10641380
MYH3not provided, Freeman-Sheldon syndrome, Arthrogryposis multiplex congenita
Conflicting interpretations of pathogenicity
(Nov 4, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr17:10543994
GRCh38:
Chr17:10640677
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
91.
GRCh37:
Chr17:10543876
GRCh38:
Chr17:10640559
MYH3Distal arthrogryposis type 2B1, not provided, Freeman-Sheldon syndrome
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr17:10543705
GRCh38:
Chr17:10640388
MYH3A791TFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
93.
GRCh37:
Chr17:10543509
GRCh38:
Chr17:10640192
MYH3P829LFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1, not provided,
Inborn genetic diseases
Uncertain significance
(May 16, 2023)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr17:10543133
GRCh38:
Chr17:10639816
MYH3Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1, not provided
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
95.
GRCh37:
Chr17:10542989
GRCh38:
Chr17:10639672
MYH3T938KFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
96.
GRCh37:
Chr17:10542678
GRCh38:
Chr17:10639361
MYH3not provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1
Benign/Likely benign
(Feb 15, 2021)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr17:10542472
GRCh38:
Chr17:10639155
MYH3R1046Qnot provided, Freeman-Sheldon syndrome, Distal arthrogryposis type 2B1,
Inborn genetic diseases
Conflicting interpretations of pathogenicity
(Mar 18, 2022)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr17:10542470
GRCh38:
Chr17:10639153
MYH3V1047IFreeman-Sheldon syndrome, not provided, Distal arthrogryposis type 2B1
Conflicting interpretations of pathogenicity
(Dec 31, 2019)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr17:10542436
GRCh38:
Chr17:10639119
MYH3G1058EFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr17:10541650
GRCh38:
Chr17:10638333
MYH3L1147MFreeman-Sheldon syndrome, Distal arthrogryposis type 2B1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination